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Abstract
The activities of aspirin (acetylsalicylic acid)-esterases were measured
in several tissues (liver, kidney, adrenal glands, brain and serum) from
adult male and female Wistar rats. In males, both aspirin-esterase I
(assayed at pH 5.5) and II (assayed at pH 7.4) activities were higher in
liver homogenates when compared to females (aspirin-esterase I:
males 48.9 ± 4.8 (N = 8) and females 29.3 ± 4.2 (N = 8) nmol of
salicylic acid formed min-1 mg protein-1; aspirin-esterase II: males
41.4 ± 4.1 (N = 8) and females 26.1 ± 4.5 (N = 8) nmol of salicylic acid
formed min-1 mg protein-1, P<0.001). In serum, enzyme activity was
higher in females than in males (aspirin-esterase I: males 0.85 ± 0.06
(N = 6) and females 1.18 ± 0.11 (N = 6) nmol of salicylic acid formed
min-1 mg protein-1; aspirin-esterase II: males 1.03 ± 0.13 (N = 6) and
females 1.34 ± 0.11 (N = 6) nmol of salicylic acid formed min-1 mg
protein-1, P<0.001). In the other tissues assayed, no statistically sig-
nificant difference between males and females was found. There were
no statistically significant differences when the enzymes were assayed
in different phases of the estrous cycle in liver and serum. These
results show that the differences in aspirin-esterase activity observed
between males and females are not due to the estrous cycle. The gender
difference obtained in our study may indicate an involvement of
gonadal hormones in the control of the hydrolysis of aspirin. This
possibility is currently under investigation.
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Introduction
Aspirin (acetylsalicylic acid) (ASA) is
the drug most frequently used worldwide.
Several pharmacological actions have been
attributed to aspirin, e.g. analgesic, anti-
pyretic, anti-inflammatory activities, etc.
Aspirin metabolism starts by hydrolysis pro-
moted by esterases (aspirin-esterases) found
in several tissues (1-5). Salicylic acid (SA),
the product of aspirin hydrolysis, does not
have the same pharmacological actions as
aspirin (6-11). Some investigators have pro-
posed that the rate of aspirin hydrolysis has
an important role in the pharmacological
action and toxicity of salicylates (1,12,13).
Several enzyme activities have been
shown to differ between males and females
(14-18). These sex differences were shown
to occur mostly in liver tissue and they seem
to be determined early in life (15). In adults
they are under control of sex hormones and
the pituitary (15-17). Some reports have dem-
onstrated a sex difference in the action of
aspirin, e.g., in rats the inhibitory effect on
Ca2+ mobilization in platelets produced by
aspirin is higher in males than in females
(19), in bulls the aspirin toxicity (LD50) is
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higher in females than in males (20), in
rabbits aspirin decreases thrombin size in
males but not in females (21), in humans
aspirin is effective in reducing the extent of
platelet-subendothelium interaction in males
but not in females (22) and inhibition of
platelet aggregation is higher in females than
in males (23).
A gender difference in aspirin hydrolysis
in human plasma was demonstrated and as-
pirin hydrolysis was shown to be higher in
males (3). A similar sex difference in aspirin
hydrolysis was also shown in serum, i.e., a
higher enzymatic activity in males than in
females, and aspirin-esterase activity in rat
liver homogenates has been reported to be
lower in females than in males (1). However,
these authors did not present any data nor
did they provide a reference where these
results could be found. Therefore, we may
assume that they did not perform a systema-
tic study of aspirin-esterase activity compar-
ing males to females.
To our knowledge, the present paper is
the first to report a difference in the activity
of aspirin-esterases between male and fe-
male rats in a systematic study of different
tissues.
Material and Methods
Subjects
Adult male and female Wistar rats, 4
months old, from our breeding colony were
used in the experiments. Rats had free access
to tap water and Purina® lab chow before
sacrifice. After weaning they were kept in
wire cages (3 rats/cage) in a room with con-
trolled temperature (22oC) and a 12-h light/
dark cycle (lights on from 7:00 a.m. to 7:00
p.m.).
The phases of the estrous cycle were
determined daily by standard laboratory pro-
cedures before sacrifice. Only those animals
presenting a well-defined estrous cycle were
used in the experiment.
Homogenate preparation
All animals were sacrificed by decapitation
in the morning. Trunk blood was collected
into test tubes using plastic funnels. After
coagulation, blood was centrifuged for 15 min
at 900 g at 0oC and serum transferred to glass
test tubes. Serum was kept frozen at -20oC
until assayed. Whole brains, liver, kidneys and
adrenal glands were excised rapidly, wrapped
in parafilm followed by aluminum foil and
frozen at -20oC until assayed. Serum was used
in the assays without any modification. Homo-
genates from liver, kidneys, adrenal glands
and brains were prepared with cold 0.15 M
KCl. Fragments of liver and kidneys, whole
adrenal glands and brain were used to obtain
the homogenates. Tissue was weighed while
frozen, and cold 0.15 M KCl was added in
appropriate volumes. Homogenates (5% liver
and kidney and 10% brain and adrenal glands)
were prepared in a motor driven teflon pestle
glass homogenizer (20 strokes). Homogenates
(liver and kidney) were centrifuged for 15 min
at 2250 g and the supernatants were collected
for enzyme assays run on the same day the
homogenates were obtained. Samples were
kept at 4oC over crushed ice during all manipu-
lations.
Aspirin-esterases determination
Based on several criteria, two aspirin-
esterases were determined and named aspi-
rin-esterase I and II (2). These esterases can
be assayed using different buffers. We meas-
ured the two aspirin-esterases in our assays
using a method based on the native fluores-
cence of SA (24). Tissue samples (20 µl)
were incubated in duplicate with 80 µl of
ASA (diluted in 0.2 M Tris/HCl buffer, pH
7.4, for aspirin-esterase II or 0.2 M acetate
buffer, pH 5.5, for aspirin-esterase I) at 37oC
in a shaking water bath. The final concentra-
tion of aspirin in the incubations was 8 mM.
The reaction was halted by adding 50 µl of
cold 10% trichloroacetic acid (w/v). Blanks
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for monitoring the spontaneous hydrolysis
of aspirin were obtained by adding 50 µl of
trichloroacetic acid before incubation and
were run in duplicate. After centrifugation at
2250 g at 0oC for 15 min a 20-µl aliquot from
the clear supernatant was transferred to a test
tube containing 380 µl of buffer used for
incubation. After vortexing the samples, SA
fluorescence was read in a Hitachi-Perkin
Elmer fluorometer at 305 (excitation)-405
(emission) nm. SA standard curves were
obtained by diluting a 5-mM SA stock solu-
tion. SA concentrations ranged from 0.125
mM to 5 mM. Twenty microliters (2.5 to 100
nanomoles) of each SA concentration was
mixed with 80 µl of incubation buffer and 50
µl of trichloroacetic acid. Then, after vortex-
ing, a 20-µl aliquot was transferred to a test
tube containing 380 µl of the same buffers as
used previously. The solution was vortexed
and read at 305-405 nm. The amount of SA
formed enzymatically was calculated as nmol
by subtracting the blank relative fluores-
cence unit reading (spontaneous hydrolysis)
from the total relative fluorescence unit read-
ing (enzymatic plus spontaneous hydroly-
sis). The resulting relative fluorescence unit
reading due to enzymatic hydrolysis was
interpolated in the SA standard curve and
the amount of SA formed enzymatically was
determined. The SA standard curve was lin-
ear throughout the entire range of SA con-
centrations used. The enzyme assays were
run in the linear range for both incubation
time and protein concentration. Enzyme ac-
tivity is reported as nmol SA formed min-1
mg protein-1.
All reagents used were of analytical grade
and the best commercially available. Twice-
distilled water was used to prepare the solu-
tions. Aspirin and SA were synthesized and
kindly donated by Novaquímica Labo-
ratórios, São Bernardo, SP, Brazil.
Protein measurement
Proteins were measured by the method of
Lowry et al. (25) using bovine serum albu-
min as standard.
Statistics
Results were analyzed statistically by one-
way analysis of variance (one-way ANOVA)
and by the two-tailed Student t-test, with the
level of significance set at P≤0.05, two-tailed.
Table 1 - Aspirin-esterase I specific activity in tis-
sues from adult male and female rats.
Serum and brain homogenates were incubated
for 20 min and liver and kidney homogenates
were incubated for 10 min at 37oC at pH 5.5.
Aspirin-esterase I activity was assayed at a final
aspirin concentration of 8 mM. Results are re-
ported as nmol SA formed min-1 mg protein-1
(mean ± SD). The number of animals is given
within parentheses. *P<0.001  vs respective value
for males (Student t-test).
Males Females
Liver 48.9 ± 4.8 (8) 29.3 ± 4.2 (8)*
Kidney 36.1 ± 4.8 (8) 38.1 ± 3.5 (8)
Brain 4.44 ± 0.33 (8) 4.39 ± 0.39 (8)
Serum 0.85 ± 0.06 (6) 1.18 ± 0.11 (6)*
Table 2 - Aspirin-esterase II specific activity in
tissues from adult male and female rats.
Serum, adrenal glands and brains were incubated
for 20 min, and liver and kidneys were incubated
for 10 min at 37oC at pH 7.4. Aspirin-esterase II
was assayed at a final aspirin concentration of 8
mM. Results are reported as nmol SA formed
min-1 mg protein-1 (mean ± SD). The number of
animals is given within parentheses. *P<0.001 vs
respective value for males (Student t-test).
Males Females
Liver 41.4 ± 4.1 (8) 26.1 ± 4.5 (8)*
Kidney 35.3 ± 3.0 (8) 37.4 ± 3.5 (8)
Adrenal 4.99 ± 0.18 (4) 4.69 ± 0.21 (4)
glands
Brain 2.24 ± 0.32 (8) 2.08 ± 0.33 (8)
Serum 1.03 ± 0.13 (6) 1.34 ± 0.11 (6)*
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Results
Tables 1-4 show the results obtained in
this study for aspirin-esterases I and II. As
can be seen in the Tables, liver homogenate
presented the highest enzyme specific activ-
ity for both aspirin-esterases I and II, whereas
serum showed the lowest specific activity.
The statistical comparison between males
and females showed that for both aspirin-
esterase I and II males presented a higher
specific activity in liver tissue (P<0.001). In
serum the opposite was observed with fe-
males showing higher specific activity than
males for both enzymes (P<0.001). Statisti-
cal analysis of brain, kidney and adrenal
gland data showed no difference between
males and females.
Tables 3 and 4 show the results of en-
zyme activity during the estrous cycle of
females. There were no statistically signifi-
cant differences in liver aspirin-esterase II
(F3,24 = 0.83, P>0.05) or serum aspirin-es-
terase I (F3,24 = 1.18, P>0.05) and II (F3,24 =
0.91, P>0.05) activities.
Discussion
The present results show that male and
female rats differ in the rate of aspirin hy-
drolysis promoted by pH-dependent aspirin-
esterases. This difference was specific since
it was observed in liver and serum but not in
brain, adrenal glands or kidneys. Males
showed higher rates of aspirin-esterase ac-
tivity in liver when compared to females,
whereas females showed higher enzyme ac-
tivity in serum. The possible influence of the
estrous cycle on this sex difference in aspi-
rin-esterase activity can be ruled out since
our data (Tables 3 and 4) showed no differ-
ence in enzyme activity throughout the es-
trous cycle of females. Plasma and serum
aspirin-esterase activities are higher in hu-
man males than in females (1,3) and in rats
the sex difference is the opposite, with fe-
males showing higher rates. In contrast, male
rats showed higher aspirin-esterase activity
in the liver. The difference in enzyme activ-
ity in liver demonstrated here in rats suggests
that this phenomenon should be explored in
humans.
Besides having a major role in xenobiotic
metabolism, the liver is also the site of syn-
thesis for blood proteins, and therefore it is
possible that the aspirin-esterases measured
in serum are synthesized in the liver. Ac-
cording to our results, the specific activity of
aspirin-esterases is much lower in serum
Table 3 - Rat serum aspirin-esterase I and II specif-
ic activity at different phases of the estrous cycle.
Serum was incubated for 20 min. Aspirin-esterase
I and II activities were assayed at a final aspirin
concentration of 8 mM. Results are reported as
the mean ± SD. The number of animals is given
within parentheses. Overall mean for aspirin-es-
terase I specific activity was 1.24 ± 0.18 (N = 28)
and for aspirin-esterase II was 1.09 ± 0.15 (N =
28).
Estrous Aspirin-esterase specific activity
cycle (nmol SA formed min-1 mg protein-1)
phases
I II
Diestrus I 1.27 ± 0.11 (7) 1.02 ± 0.13 (7)
Diestrus II 1.27 ± 0.19 (7) 1.06 ± 0.12 (7)
Proestrus 1.30 ± 0.26 (7) 1.17 ± 0.20 (7)
Estrus 1.15 ± 0.12 (7) 1.10 ± 0.12 (7)
Table 4 - Rat liver aspirin-esterase II specific activ-
ity during the estrous cycle.
Liver homogenate was incubated for 10 min at
37oC, pH 7.4. Aspirin-esterase II activity was as-
sayed at a final aspirin concentration of 8 mM. The
results are reported as the mean ± SD. Overall
enzyme mean activity was 30.3 ± 4.0 (N = 28).
The number of animals is given within parenthe-
ses.
Estrous Aspirin-esterase II specific activity
cycle (nmol SA formed min-1 mg protein-1)
phases
Diestrus I 31.7 ± 2.4 (7)
Diestrus II 32.5 ± 5.4 (7)
Proestrus 28.3 ± 2.9 (7)
Estrus 28.8 ± 3.6 (7)
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than in liver. This suggests that although
aspirin metabolism may start in the blood
after absorption, the liver would be respon-
sible for most of its hydrolysis. In the liver of
male rats there is a higher aspirin-esterase
activity than in the liver of females, whereas
the serum of females has higher activity.
Whether this difference is due to a different
amount of enzymes released into the blood
still needs to be determined.
We have measured aspirin-esterase ac-
tivities in liver homogenate supernatants
obtained by 2250 g centrifugation. This
preparation allows only to discard cell nu-
clei, vessels and large cell debris. Aspirin-
esterases correspond to several enzymes, both
particulate and soluble (4,5). Since we have
assayed both particulate and soluble enzymes
further experiments are necessary to deter-
mine if the differences reported here are due
to a specific isozyme, soluble or particulate,
or to all aspirin-hydrolyzing enzymes.
Since the pharmacokinetics of aspirin
involves other important steps (26,27), it is
necessary to determine if male and female
rats also differ in the overall aspirin meta-
bolic pathway to fully understand possible
pharmacological differences in aspirin ac-
tion between genders.
Most of the gender differences in drug
metabolism are under hormonal control and
androgens seem to play a pivotal role in this
difference (15-17). This possibility is cur-
rently under investigation in our laboratory
and preliminary results show that at least in
males androgens are responsible for the liver
sex difference reported here.
In conclusion, we have shown that aspi-
rin-esterase activities in rat tissues differ
between males and females. These data may
have implications in the differences in the
pharmacokinetics and pharmacological ef-
fects of aspirin between males and females.
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